Expert Opinion on Therapeutic Targets

Targeting pleiotropin to treat osteoarthritis
pp. 861-867(7)
Author: Mentlein, Rolf

STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses
pp. 869-880(12)
Authors: Gao, Hongwei; Ward, Peter A

The renal H⁺, K⁺-ATPases as therapeutic targets
pp. 881-890(10)
Authors: Zies, Deborah L; Gumz, Michelle L; Wingo, Charles S; Cain, Brian D

Targeting the α₉α₁₀ nicotinic acetylcholine receptor to treat severe pain
pp. 891-897(7)
Authors: Vincler, Michelle; McIntosh, J Michael

Enviromimetics: exploring gene environment interactions to identify therapeutic targets for brain disorders
pp. 899-913(15)
Authors: McOmish, Caitlin E; Hannan, Anthony J

Targeting cancer stem cells
pp. 915-927(13)
Authors: Kvinlaug, Brynn T; Huntly, Brian JP

Novel therapeutic targets in mantle cell lymphoma
pp. 929-940(12)
Authors: Martin, Peter; Leonard, John P

Immunomodulating role of bisphosphonates on human gamma delta T cells: an intriguing and promising aspect of their antitumour activity
pp. 941-954(14)
Authors: Galluzzo, S; Santini, D; Vincenzi, B; Caccamo, N; Meraviglia, F; Salerno, A; Dieli, F; Tonini, G

FOXP1: a potential therapeutic target in cancer
pp. 955-965(11)
Authors: Koon, Henry B; Ippolito, Gregory C; Banham, Alison H; Tucker, Philip W

Targeting enzyme inhibitors in drug discovery
pp. 967-978(12)
Authors: Copeland, Robert A; Harpel, Mark R; Tummino, Peter J

Statins and telomere length: risk assessment and management for coronary heart disease
pp. 979-982(4)
Author: Tiwari, Atul

5th annual conference on Cytokines and Inflammation
pp. 983-987(5)
Authors: Numerof, Robert P; Blasko, Eric